{
  "title": "Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar ",
  "score": 247,
  "selftext": "Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike.\n\nShares of Eli Lilly jumped more than 9% in premarket trading Thursday.\n\nThe drugmaker now expects full-year adjusted earnings of $16.10 to $16.60, up from a previous guidance of $13.50 to $14 per share.\n\nThe company also expects revenue for the year to come in between $45.4 billion and $46.6 billion, an increase of $3 billion at both ends of the range.\n\nThe results come almost one week after the Food and Drug Administration said all doses of Zepbound and Mounjaro are available in the U.S. after extended shortages. Demand has far outstripped supply for those incretin drugs, which mimic hormones produced in the gut to suppress a person‚Äôs appetite and regulate their blood sugar.\n\nHere‚Äôs what Eli Lilly reported for the second quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: \n\nEarnings per share: $3.92 adjusted vs. $2.60 expected\n\nRevenue: $11.30 billion vs. $9.92 billion expected\n\nThe pharmaceutical giant booked net income of $2.97 billion, or $3.28 a share, for the second quarter. That compares with a profit of $1.76 billion, or $1.95 a share, a year earlier. \n\nExcluding one-time items associated with the value of intangible assets and other adjustments, Eli Lilly posted earnings of $3.92 per share for the second quarter of 2024.\n\nThe company posted second-quarter revenue of $11.30 billion, up 36% from the same period a year ago. \n\nShares of Eli Lilly are up more than 30% this year after jumping almost 60% in 2023 due to the soaring demand for the company‚Äôs weight loss and diabetes drugs ‚Äì and increased investor interest in their potential as treatments for other health conditions. That popularity comes despite their hefty monthly price tags, inconsistent insurance coverage and intermittent supply shortages. \n\nWith a market cap of more than $730 billion, Eli Lilly is the largest pharmaceutical company based in the U.S.\n\nSource: https://www.cnbc.com/2024/08/08/eli-lilly-lly-earnings-q2-2024.html",
  "link_flair_text": null,
  "id": "1en3g1b",
  "num_comments": 50,
  "created_utc": 1723116343,
  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/",
  "comments": [
    {
      "id": "lh3i2dk",
      "score": 116,
      "body": "I‚Äôm fully in the camp that LLY will be a top 5 market cap company within the decade. Once all their new facilities are built to supply their new weight loss products and can actually meet demand, this company will go nuts.",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3i2dk/",
      "created": 1723120002,
      "depth": 0,
      "replies": [
        {
          "id": "lh3y3hg",
          "score": 41,
          "body": "Out of every stock I can think of, they have the easiest bull case to understand. Obesity is a huge issue and they have the best approved drugs and even more in their pipeline.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3y3hg/",
          "created": 1723125924,
          "depth": 1,
          "replies": [
            {
              "id": "lh49wjy",
              "score": 15,
              "body": "Also, Mounjaro is the preferred drug for type 2 diabetes over Ozempic. It‚Äôs supposedly easier on the system (source: my liver Dr)",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh49wjy/",
              "created": 1723129714,
              "depth": 2,
              "replies": [
                {
                  "id": "lh4sdj2",
                  "score": 7,
                  "body": "I tried both, Mounjaro is by far superior. As soon as I had my first Mounjaro shot, I knew it was a game changer and put like 10k long term into Eli.",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4sdj2/",
                  "created": 1723135409,
                  "depth": 3,
                  "replies": []
                },
                {
                  "id": "lh4m9tv",
                  "score": 8,
                  "body": "I don't believe Mounjaro is easier on the system. Both Ozempic and Mounjaro act in the same manner (with Mounjaro having another component for how it works). If Ozempic is harder on the system, Mounjaro would be as well since they both work in similar fashion. Looking at both clinical trials they had similar side effects. It'll also take a few years to see how the side effects pan out for non-diabetic patients.\n\nAnd, Mounjaro is not the preferred drug for T2DM. It has a higher weight loss reduction than Ozempic so it may be prescribed more often but Ozempic and other drugs in that class are also being classified as first-line again due to the weight loss.\n\nIn actual practice if your A1c or blood glucose levels aren't incredibly high, a lot of doctors start on Metformin because it's super cheap and likely won't need extra steps to be paid for by insurance. Then, they'll put you on a number of different drugs based on your overall health.",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4m9tv/",
                  "created": 1723133542,
                  "depth": 3,
                  "replies": [
                    {
                      "id": "lh9rh4g",
                      "score": 1,
                      "body": "They aren't the same. Tirzepatide (Mounjaro) acts both as a GIP and GLP1 agonist, while Ozempic (semaglutide) is only a GLP1 agonist. Tirzepatide is a more effective drug, it has a stronger weight loss effect.",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh9rh4g/",
                      "created": 1723209370,
                      "depth": 4,
                      "replies": [
                        {
                          "id": "lha9qco",
                          "score": 2,
                          "body": "You just repeated what I said. They're the same in terms of side effects because they both are GLP 1 agonists. If Ozempic has certain side effects, Mounjaro is likely to have them as well. And yes, drugs in the same class can have different side effects but it's unlikely Ozempic is \"harder on the system\" without Mounjaro being the same. And yes, Mounjaro has a stronger weight loss effect which is why I said it may be used quicker in T2DM because a lot of diabetics are overweight.\n\nThere isn't any reliable evidence that says Ozempic is \"harder on the system\" whatever that means.",
                          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lha9qco/",
                          "created": 1723215565,
                          "depth": 5,
                          "replies": []
                        }
                      ]
                    },
                    {
                      "id": "lhlntqu",
                      "score": 0,
                      "body": "Just because they bind same receptors does not mean their chemical structures and metabolites are same. Flight chemical structure differences can mean a lot of difference in metabolism and toxicity. You can have multiple molecules in same drug class with vastly different safety profiles based on how the body processes the molecule.",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lhlntqu/",
                      "created": 1723390333,
                      "depth": 4,
                      "replies": []
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "id": "lh3y8wg",
          "score": 19,
          "body": "They need to at least grow 5x their revenue and earnings for the next 10Y in order to justify half of their current valuation. I dk if weight loss product can provide such tremendous value? Perhaps 3x at max",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3y8wg/",
          "created": 1723125974,
          "depth": 1,
          "replies": [
            {
              "id": "lh4ds15",
              "score": 5,
              "body": "There are a lot of studies looking at what else GLP-1 meds treat in addition to obesity because it reduces chronic inflammation and other things. Eg, a trial wrapped up recently showing that it is effective at treating sleep apnea",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4ds15/",
              "created": 1723130926,
              "depth": 2,
              "replies": [
                {
                  "id": "lh4n0gc",
                  "score": 3,
                  "body": "Majority of analysts predict that GLP-1 will reach 100B market size by 2030, also the range of predicted market CAGR is set between 28%-50%. I‚Äôm optimistic at the moment and perhaps also for the coming years",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4n0gc/",
                  "created": 1723133768,
                  "depth": 3,
                  "replies": []
                }
              ]
            }
          ]
        },
        {
          "id": "lh3oxap",
          "score": 17,
          "body": "LLY and NVO are a large part of my portfolio in term of individual stocks.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3oxap/",
          "created": 1723122704,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh3tu8z",
          "score": 14,
          "body": "Turned down a job with lilly 5 years ago üíÄ",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3tu8z/",
          "created": 1723124481,
          "depth": 1,
          "replies": [
            {
              "id": "lh3wo9j",
              "score": 20,
              "body": "I work in the industry and have close friends at Lilly. They are over-worked trying to get their new lines up and running and the wages and benefits are very middle-of-the-pack compared to other pharmaceutical and biotech companies. Turnover there is quite high. They also do not offer RSU‚Äôs unless you are an executive so most employees are not benefiting from their stock climb.\n\nFrom a work/life balance and compensation perspective, unless you absolutely need a job you dodged a bullet.",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3wo9j/",
              "created": 1723125446,
              "depth": 2,
              "replies": [
                {
                  "id": "lh3z1q9",
                  "score": 17,
                  "body": "Well this isn‚Äôt exactly true. I have a very close direct family member that works for Lilly. \n\nThey have a really good company pension. Their 401k match is just about the same as any other company. Their health insurance is very good. The company pays for the majority of your family health insurance for life if you retire from the company with X amount of years. My family member got RSU‚Äôs 3 years in a row and they are nowhere near an executive. Their bonus multiplier the past few years has been between 150-200%. Their pay has greatly increased since covid to compete with the market, and on top of that many of their locations are in very LCOL locations.",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3z1q9/",
                  "created": 1723126239,
                  "depth": 3,
                  "replies": [
                    {
                      "id": "lh3zsho",
                      "score": 3,
                      "body": "All of those benefits you mentioned are available at most pharmaceutical companies (I‚Äôve worked for Novo and a few others) and you‚Äôll have a better work-life balance elsewhere.\n\nNovo gives 9% toward your 401k and you don‚Äôt have to put in a single penny to get that. The pay and health insurance are equivalent, and you‚Äôll work way less.\n\nSame story with Biogen and FujiFilm Diosynth.\n\nNovo, Biogen and Fuji in particular have a large North Carolina presence where COL is relatively low.",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3zsho/",
                      "created": 1723126485,
                      "depth": 4,
                      "replies": []
                    }
                  ]
                },
                {
                  "id": "lh4nmpg",
                  "score": 5,
                  "body": "I‚Äôm in final stage of interviews at Lilly, currently working at a different big pharma. The Lilly offer is insanely competitive. It‚Äôs a lateral move, yet the salary band STARTS higher than my current salary. Plus equity is included in the compensation and my bonus % is higher than I currently make.",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4nmpg/",
                  "created": 1723133959,
                  "depth": 3,
                  "replies": []
                }
              ]
            }
          ]
        },
        {
          "id": "lh4figc",
          "score": 2,
          "body": "They need to grow at an insane rate. More than anticipated for the stock to meet current price. Look at their PE ratio.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4figc/",
          "created": 1723131460,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh3vcim",
          "score": 4,
          "body": "Bold prediction.\n\nThe current top 5 tech companies are no slouches. Huge profits, great balance sheets and all growing double digit except AAPL which may accelerate with the new product lineup \"mega upgrade cycle\".\n\nMy concern with LLY future growth potential is the price of their products. There are a lot of people who can afford them, the middle-upper class and upper, and they're likely the current customers. There are a lot more people with the means.\n\nBut eventually they need more customers to continue to grow to overtake the top 5. The highest percentage of obese people are in the lower income bracket. That would be their prime audience. Yet they cannot afford LLY products. It's a considerable expense for the middle class too.\n\nThen you have to consider new competing weight loss products from other drug companies now that they see how lucrative it is. \n\nI would bet my money on the big tech companies keeping their spots",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3vcim/",
          "created": 1723124998,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh92fuz",
          "score": 1,
          "body": "Just remember though,  lots of competition is going to hit the market in the coming couple of years,  at least one will be just as effective or maybe more.  Also remember in this industry there are very finite patents..\n\nI'd recommend actually building a DCF model,  they are not going to realize permanent FCF growth perpetually so the valuation eventually becomes are to justify.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh92fuz/",
          "created": 1723197503,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh3sk7a",
          "score": 1,
          "body": "Within 3 years",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3sk7a/",
          "created": 1723124031,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh4mp25",
          "score": 0,
          "body": "Well, at least until people figure out firsthand that when they stop these drugs they become fatter than ever",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4mp25/",
          "created": 1723133671,
          "depth": 1,
          "replies": []
        }
      ]
    },
    {
      "id": "lh3qvoj",
      "score": 48,
      "body": "pharmacist here. been buying this one on the way down. zepbound/mounjaro scripts have been outnumbering the wegovy/ozempic scripts lately. zepbound is $550 after manufacturer coupon and cheaper than wegovy. people have no problem paying somehow. they dont even hesitate. not sure how they afford it every month. they treat is as a necessity, along the same lines as rent or food.",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3qvoj/",
      "created": 1723123426,
      "depth": 0,
      "replies": [
        {
          "id": "lh45j3j",
          "score": 31,
          "body": "They are saving $500/mo on fast food",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh45j3j/",
          "created": 1723128335,
          "depth": 1,
          "replies": []
        },
        {
          "id": "lh48a9r",
          "score": 3,
          "body": "Everyone wants to be an instagram model lol",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh48a9r/",
          "created": 1723129203,
          "depth": 1,
          "replies": [
            {
              "id": "lh4hcww",
              "score": 9,
              "body": "I'm sure tons of people are using it for vanity sake, but I have a couple people in my life using it for actual necessary weight loss.\n\nMy SIL is one of them, gained lots of weight postpartum due to crazy hormonal imbalances. The doc told her she needed to lose 60+ lbs to help level things out, but she was only losing a lb a month on an extremely restrictive caloric deficit + daily exercise. She got a script for Zepbound and started losing 10+lbs a month without any change to her diet or exercise routine. She should hit her goal weight in a couple months, and plans on stopping Zepbound then. Basically \\~$4.5k to cut multiple years off of her weight loss plan, seems pretty worth it IMO.",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4hcww/",
              "created": 1723132026,
              "depth": 2,
              "replies": [
                {
                  "id": "lh4mehx",
                  "score": 1,
                  "body": "[deleted]",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4mehx/",
                  "created": 1723133582,
                  "depth": 3,
                  "replies": [
                    {
                      "id": "lh5xl9w",
                      "score": 3,
                      "body": "I mean it's possible she's lying, but you're incorrect that tirzepatide has no direct effect on fat loss.¬†¬†\n\n\nMany people that find it extremely difficult to lose weight are insulin resistant. If your cells don't respond well to insulin, you're going to store more fat than normal and hold onto that fat even in a caloric deficit. Tirzepatide has shown to improve insulin sensitivity and increase insulin secretion, which is going to help you burn off fat and store less of it.¬†¬†¬†\n\n\nCalories in and calories out matters the most, but there are people who are going to have a much more difficult time losing weight due to hormonal imbalances causing metabolic issues, insulin resistance, and other things.¬†It's the reason why some people who get thyroid cancer gain massive amounts of weight, their hormones go out of whack and their metabolism comes to a screeching halt.¬†¬†\n\n\nMy SIL is also a registered dietitian, so she knows how to track her calories and eat properly for weight loss. I find it difficult to believe she was self-sabotaging or something and lying about it.",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh5xl9w/",
                      "created": 1723147873,
                      "depth": 4,
                      "replies": [
                        {
                          "id": "lh5yrgk",
                          "score": 1,
                          "body": "[deleted]",
                          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh5yrgk/",
                          "created": 1723148226,
                          "depth": 5,
                          "replies": [
                            {
                              "id": "lh62d4z",
                              "score": 1,
                              "body": ">You started off by saying it has no direct fat loss, and then continued on with an indirect reason tirzepatide aids fat loss, and then continued on with an indirect reason tirzepatide aids fat loss\n\n\nWhat? I never said \"it has no direct fat loss\", whatever that means.¬†\n\n\n>Edit: most don‚Äôt have issues with thyroids, but as mentioned.. a small do\n\n\nSo you do agree that there are people who have issues that make it extremely difficult to lose weight even when on a strong calorie restricted diet, right? Thyroid issues = hormonal issues. Hormonal issues are not exclusive to thyroid problems (e.g. my SIL's hormonal imbalances postpartum).\n\n\n>when I‚Äôm deep into a ‚Äúbulk‚Äù and have a higher body fat percentage, my blood glucose is usually in not the most optimal of levels either. This causes more fat gain, rather than muscle\n\n\nOkay... so then you understand why calories in vs. calories out alone does not fully explain the nuances of fat gain/loss.¬†",
                              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh62d4z/",
                              "created": 1723149294,
                              "depth": 6,
                              "replies": []
                            }
                          ]
                        },
                        {
                          "id": "lh6qm7w",
                          "score": 0,
                          "body": "Lmao",
                          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh6qm7w/",
                          "created": 1723157208,
                          "depth": 5,
                          "replies": []
                        }
                      ]
                    },
                    {
                      "id": "lh5q3h4",
                      "score": 1,
                      "body": "[deleted]",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh5q3h4/",
                      "created": 1723145623,
                      "depth": 4,
                      "replies": []
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "id": "lh3nfgj",
      "score": 35,
      "body": "My average share prices is $920 üíÄ",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3nfgj/",
      "created": 1723122139,
      "depth": 0,
      "replies": [
        {
          "id": "lh4dmv4",
          "score": 10,
          "body": "Lucky you.  \n\nYou liked the company at $920/share and now you can get more shares at 835.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4dmv4/",
          "created": 1723130881,
          "depth": 1,
          "replies": [
            {
              "id": "lh4sjho",
              "score": 6,
              "body": "Bold of you to assume he has any money left",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4sjho/",
              "created": 1723135460,
              "depth": 2,
              "replies": []
            }
          ]
        }
      ]
    },
    {
      "id": "lh3qmg6",
      "score": 23,
      "body": "Inherited 200 shares at a avg of $368. I'll hold until I die and can pass it to my son.",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3qmg6/",
      "created": 1723123333,
      "depth": 0,
      "replies": []
    },
    {
      "id": "lh5bp6b",
      "score": 5,
      "body": "wayland yutani corporation anyone?",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh5bp6b/",
      "created": 1723141264,
      "depth": 0,
      "replies": []
    },
    {
      "id": "lh3rvu0",
      "score": 8,
      "body": "Added some when there was the premarket dip on Monday. I think they are well-positioned in the weight loss space and revenue growth is solid.",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3rvu0/",
      "created": 1723123789,
      "depth": 0,
      "replies": []
    },
    {
      "id": "lh87ugr",
      "score": 1,
      "body": "!remindme 2 weeks",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh87ugr/",
      "created": 1723178561,
      "depth": 0,
      "replies": [
        {
          "id": "lh87yb1",
          "score": 1,
          "body": "I will be messaging you in 14 days on [**2024-08-23 04:42:41 UTC**](http://www.wolframalpha.com/input/?i=2024-08-23%2004:42:41%20UTC%20To%20Local%20Time) to remind you of [**this link**](https://www.reddit.com/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh87ugr/?context=3)\n\n[**CLICK THIS LINK**](https://www.reddit.com/message/compose/?to=RemindMeBot&subject=Reminder&message=%5Bhttps%3A%2F%2Fwww.reddit.com%2Fr%2Fstocks%2Fcomments%2F1en3g1b%2Feli_lilly_blows_past_estimates_hikes_guidance_as%2Flh87ugr%2F%5D%0A%0ARemindMe%21%202024-08-23%2004%3A42%3A41%20UTC) to send a PM to also be reminded and to reduce spam.\n\n^(Parent commenter can ) [^(delete this message to hide from others.)](https://www.reddit.com/message/compose/?to=RemindMeBot&subject=Delete%20Comment&message=Delete%21%201en3g1b)\n\n*****\n\n|[^(Info)](https://www.reddit.com/r/RemindMeBot/comments/e1bko7/remindmebot_info_v21/)|[^(Custom)](https://www.reddit.com/message/compose/?to=RemindMeBot&subject=Reminder&message=%5BLink%20or%20message%20inside%20square%20brackets%5D%0A%0ARemindMe%21%20Time%20period%20here)|[^(Your Reminders)](https://www.reddit.com/message/compose/?to=RemindMeBot&subject=List%20Of%20Reminders&message=MyReminders%21)|[^(Feedback)](https://www.reddit.com/message/compose/?to=Watchful1&subject=RemindMeBot%20Feedback)|\n|-|-|-|-|",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh87yb1/",
          "created": 1723178616,
          "depth": 1,
          "replies": []
        }
      ]
    },
    {
      "id": "lh3gsnj",
      "score": -3,
      "body": "[deleted]",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3gsnj/",
      "created": 1723119463,
      "depth": 0,
      "replies": [
        {
          "id": "lh3ln4j",
          "score": 16,
          "body": "They'll move in unison. When one goes well, it's normal to expect the other to do just as well.",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3ln4j/",
          "created": 1723121452,
          "depth": 1,
          "replies": [
            {
              "id": "lh402v4",
              "score": 5,
              "body": "Not really, Novo reported yesterday and didn‚Äôt surprise as much as Lilly.",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh402v4/",
              "created": 1723126581,
              "depth": 2,
              "replies": []
            }
          ]
        },
        {
          "id": "lh3k2kw",
          "score": -2,
          "body": "Badly, presumably.¬†",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3k2kw/",
          "created": 1723120831,
          "depth": 1,
          "replies": [
            {
              "id": "lh3s5bq",
              "score": 4,
              "body": "Wrong. Novo reported poor pricing yesterday with wegovy asps being down -15% q/q and did not give any positive guidance in their earnings call. Today we saw strong sales and price performance from LLY so the market is more confident that ASPs will stay higher throughout the year. That‚Äôs why novo is also +4% today.",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3s5bq/",
              "created": 1723123883,
              "depth": 2,
              "replies": []
            }
          ]
        }
      ]
    },
    {
      "id": "lh3p6zl",
      "score": -9,
      "body": "I‚Äôm not buying it. Insurance still isn‚Äôt covering this for most people, and every other company that deals with the consumer is saying they are seeing pull backs in spending. Folks who are cutting back on normal things aren‚Äôt going to shell out $1000+ for a months supply of some drug when they can get a $10 membership to Planet Fitness, or $40 to LA Fitness if they want to be fancier.",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3p6zl/",
      "created": 1723122806,
      "depth": 0,
      "replies": [
        {
          "id": "lh3ql1a",
          "score": 15,
          "body": "But people are lazy and will look for a quick fix \n\nGyms have always been around and have never been more accessible but obesity rates continue to rise",
          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3ql1a/",
          "created": 1723123319,
          "depth": 1,
          "replies": [
            {
              "id": "lh3r072",
              "score": 0,
              "body": "I get that part, long term Lilly is fine. I‚Äôm just not buying their guidance. As soon as I read that my bullshit detector flashed red.",
              "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3r072/",
              "created": 1723123472,
              "depth": 2,
              "replies": [
                {
                  "id": "lh3tdis",
                  "score": 2,
                  "body": "Think of how much diabetes is in China.",
                  "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3tdis/",
                  "created": 1723124319,
                  "depth": 3,
                  "replies": [
                    {
                      "id": "lh3x7c4",
                      "score": 1,
                      "body": "Does the average Chinese citizen have that much money for a GLP-1. Also when has China never just made a shitty knockoff and people bought that instead. Also these drugs aren‚Äôt ground breaking per se. To think Lilly will be the only game in town for even a couple of years is absurd.",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3x7c4/",
                      "created": 1723125625,
                      "depth": 4,
                      "replies": [
                        {
                          "id": "lh3ypy9",
                          "score": 1,
                          "body": "LLYs head to head beat ozempic, so it's already the best game in town.\n\nChina knows healthcare costs for its developing population are an important piece of modernizing its society and infrastructure. China and lly will negotiate a price that works for them. Mounjaro is already approved in China, so this has already been solved.\n\nI think your skepticism is healthy, but my last point is Q2 still saw supply chain issues. Now that all doses are available per FDA, you will see sales explode, through weight watchers, Hims, and other e-medicine marketplaces as well.",
                          "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh3ypy9/",
                          "created": 1723126132,
                          "depth": 5,
                          "replies": []
                        }
                      ]
                    },
                    {
                      "id": "lh6qrw3",
                      "score": 1,
                      "body": "And Saudi, Australia, Mexico, and countless other countries....",
                      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh6qrw3/",
                      "created": 1723157264,
                      "depth": 4,
                      "replies": []
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "id": "lh4uusq",
      "score": -2,
      "body": "Someone please ELI5 why Lilly won‚Äôt buy a company like VKTX?",
      "permalink": "/r/stocks/comments/1en3g1b/eli_lilly_blows_past_estimates_hikes_guidance_as/lh4uusq/",
      "created": 1723136165,
      "depth": 0,
      "replies": []
    }
  ]
}